This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:depression [12.17.2018] – [Patient interviews] sallieq | home:diseases:depression [12.17.2018] – [Headline] sallieq | ||
---|---|---|---|
Line 50: | Line 50: | ||
In the research field of psychoneuroimmunology, | In the research field of psychoneuroimmunology, | ||
+ | |||
+ | ===== Immune signaling ===== | ||
+ | |||
+ | A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells (({{pubmed> | ||
+ | |||
===== Co-morbidity ===== | ===== Co-morbidity ===== | ||
Line 57: | Line 62: | ||
===== Management ===== | ===== Management ===== | ||
- | These preliminary | + | ==== How can I control my depression? ==== |
+ | |||
+ | |||
+ | Depression is common in Th1 diseases. It's important to recognize neuro symptoms as immunopathology so they can be managed to tolerable. See What is neuro immunopathology? | ||
+ | |||
+ | If you are having suicidal thoughts, tell someone immediately. | ||
+ | |||
+ | If your depression is intolerable, | ||
+ | |||
+ | Antidepressants | ||
+ | |||
+ | If slowing the immune response is ineffective, | ||
+ | |||
+ | Preliminary | ||
Action of SSRIs (({{pubmed> | Action of SSRIs (({{pubmed> |